Can BAK be used in corneal cross linking?
Global research team develops diagnostic model for iris melanoma
Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model
Higher prevalence of dry eye disease-related symptoms in South America
The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers
AAO 2024: Take-home results from 1 year of PTK-assisted, customised, epi-on CXL different approach for treating keratoconus
Farhad Hafezi, FARVO, MD, PhD, and colleagues reported on results achieved with phototherapeutic keratectomy-assisted, customised, epi-on corneal crosslinking
The consequences of dry eye disease: incidence of psychiatric disorders, fibromyalgia and chronic fatigue following diagnosis
Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting
Novaliq and Laboratoires Théa announce European Commission approval of ciclosporin 0.1% eye drops solution
Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye disease
Novel therapies emerge for a progressive corneal disease
Current and future options for Fuchs endothelial corneal dystrophy